Thromb Haemost 1994; 72(05): 693-697
DOI: 10.1055/s-0038-1648944
Original Article
Schattauer GmbH Stuttgart

Construction and Characterization of Thrombin-resistant Variants of Recombinant Human Protein S

Glenn T G Chang
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Leonie Aaldering
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Tilman M Hackeng
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Pieter H Reitsma
2   Thrombosis and Haemostasis Research Centre, Department of Haematology, Leiden University Hospital, The Netherlands
,
Rogier M Bertina
2   Thrombosis and Haemostasis Research Centre, Department of Haematology, Leiden University Hospital, The Netherlands
,
Bonno N Bouma
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 06. Januar 1994

Accepted after resubmission 12. Juli 1994

Publikationsdatum:
26. Juli 2018 (online)

Zoom Image

Summary

Protein S is a vitamin K-dependent plasma protein that functions as a cofactor of activated protein C (APC) in the inactivation of coagulation factors Va and Villa.

Protein S, migrates as a doublet on reduced SDS polyacrylamide gel electrophoresis. This heterogeneity in molecular weight has been explained by limited proteolysis of protein S. Human protein S contains at Arg-49, Arg-60 and Arg-70 three potential cleavage sites. Whether cleavage occurs at all three sites is not known. To study the role of these arginine residues in human protein S, we have replaced them by leucine or isoleucine. All seven possible variants were constructed: three variants with single mutations (R49L, R60L, R70I), three variants with double mutations (R49L/R60L, R60L/R70I, R49L/R70I) and one variant with a triple mutation (R49L/R60L/R70I). On reduced SDS polyacrylamide gels the single and double variants migrate as a doublet just like the wild type protein S. The triple variant migrates as a single band at a molecular weight corresponding to the upper band of the doublet. The upper band of the single and double variants but not of the triple variant could be converted into the lower band by thrombin treatment.

All variants showed cofactor activity to APC in a clotting assay. After thrombin treatment, this cofactor activity was abolished for the single (R49L, R60L, R70I) and double variants (R49L/R60L, R60L/R70I, R49L/R70I), while the triple variant (R49L/R60L/R70I) tested at several concentrations, retained its cofactor activity completely, suggesting resistance to thrombin. This shows that thrombin can cleave at all three arginine sites and that cleavage at each of these sites results in the loss of APC cofactor activity. Finally, all variants bind to C4b-binding protein with an affinity similar as the wild type recombinant molecule.